The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Ascendis Pharma A/S | COM | 04351P101 | 59,346 | 504,210 | SH | SOLE | 504,210 | 0 | 0 | ||
| Axsome Therapeutics Inc | COM | 05464T104 | 8,139 | 571,956 | SH | SOLE | 571,956 | 0 | 0 | ||
| Bellerophon Therapeutics | COM | 078771102 | 2,710 | 4,149,378 | SH | SOLE | 4,149,378 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 26,448 | 3,249,164 | SH | SOLE | 3,249,164 | 0 | 0 | ||
| Biohaven Pharmaceuticals | COM | G11196105 | 58,577 | 1,138,075 | SH | SOLE | 1,138,075 | 0 | 0 | ||
| Constellation Pharmaceuticals | COM | 210373106 | 9,846 | 726,677 | SH | SOLE | 726,677 | 0 | 0 | ||
| Gemphire Therapeutics | COM | 36870A108 | 591 | 513,752 | SH | SOLE | 513,752 | 0 | 0 | ||
| Kadmon Holdings Inc. | COM | 48283N106 | 2,165 | 820,123 | SH | SOLE | 820,123 | 0 | 0 | ||
| Kalvista Pharmaceuticals | COM | 483497103 | 16,413 | 573,482 | SH | SOLE | 573,482 | 0 | 0 | ||
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | 11,544 | 639,230 | SH | SOLE | 639,230 | 0 | 0 | ||
| La Jolla Pharmaceuticals | COM | 503459604 | 2,388 | 371,400 | SH | SOLE | 371,400 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | 3,109 | 743,876 | SH | SOLE | 743,876 | 0 | 0 | ||
| Obseva SA | COM | H5861P103 | 28,809 | 2,252,460 | SH | SOLE | 2,252,460 | 0 | 0 | ||
| Orchard RX Ltd | COM | 68570P101 | 221 | 12,383 | SH | SOLE | 12,383 | 0 | 0 | ||
| Protagonist Therapeutics Inc | COM | 74366E102 | 3,411 | 271,377 | SH | SOLE | 271,377 | 0 | 0 | ||
| Proteostasis Therapeutics Inc | COM | 74373B109 | 538 | 427,110 | SH | SOLE | 427,110 | 0 | 0 | ||
| Ra Pharmaceuticals | COM | 74933V108 | 14,168 | 632,480 | SH | SOLE | 632,480 | 0 | 0 | ||
| Shockwave Medical Inc | COM | 82489T104 | 30,165 | 901,256 | SH | SOLE | 901,256 | 0 | 0 | ||
| Spero Therapeutics Inc | COM | 84833T103 | 6,072 | 474,015 | SH | SOLE | 474,015 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 37,179 | 962,695 | SH | SOLE | 962,695 | 0 | 0 | ||
| Zogenix | COM | 98978L204 | 19,914 | 362,010 | SH | SOLE | 362,010 | 0 | 0 | ||